Novavax (NVAX) Stock Price Today & Analysis
NVAX
About Novavax
Novavax, Inc. (NASDAQ: NVAX) is a biotechnology company focused on the discovery, development, and commercialization of vaccines for serious infectious diseases. Primarily known for its development of a protein-based COVID-19 vaccine, NVAX's stock price is a key player in the pharmaceutical and biotechnology sectors.
FAQ
You can easily purchase Novavax (NVAX) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'NVAX' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Novavax with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
